Crucell N.V. (ADR) (NASDAQOTH:CRXLY.PK)
| CAPS Rating |
|
|---|
CRXLY.PK
VS S&P 500 (SPY)
CRXLY.PK News and Commentary
- Momentum Ideas: 16 Stocks Rallying on Analyst Ratings Upgrades – SeekingAlpha
- Johnson & Johnson Acquires Nearly All Of Crucell Shares – SmartMoney
- Johnson & Johnson Declares Crucell Offer Unconditional – SmartMoney
- J&J: Sufficient Number Of Crucell Holders Tender Shares – SmartMoney
- Crucell Can Resume Quinvaxem Sales, WHO Says – SmartMoney
- Crucell Large Shareholders Plan To Tender Their Stakes To J&J – SmartMoney
- Crucell Shareholder Van Herk To Tender Shares To J&J Offer – SmartMoney
- Crucell Resumes Operations At South Korean Vaccine Plant – SmartMoney
- Apple: Betting on the Impossible – SeekingAlpha
This ticker is not currently Ratable.
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Players
101
Outperform
6
Underperform
All-Star Players
26
Outperform
2
Underperform
Wall Street
1
Outperform
0
Underperform
RSS Headlines
Fool UK
